BMEA
Price
$1.85
Change
-$0.06 (-3.14%)
Updated
Jul 18 closing price
Capitalization
105.49M
14 days until earnings call
VTGN
Price
$2.56
Change
+$0.01 (+0.39%)
Updated
Jul 21, 10:58 AM (EDT)
Capitalization
74.35M
Interact to see
Advertisement

BMEA vs VTGN

Header iconBMEA vs VTGN Comparison
Open Charts BMEA vs VTGNBanner chart's image
Biomea Fusion
Price$1.85
Change-$0.06 (-3.14%)
Volume$401.68K
Capitalization105.49M
VistaGen Therapeutics
Price$2.56
Change+$0.01 (+0.39%)
Volume$100
Capitalization74.35M
BMEA vs VTGN Comparison Chart in %
Loading...
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMEA vs. VTGN commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMEA is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (BMEA: $1.85 vs. VTGN: $2.55)
Brand notoriety: BMEA and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMEA: 13% vs. VTGN: 127%
Market capitalization -- BMEA: $105.49M vs. VTGN: $74.35M
BMEA [@Biotechnology] is valued at $105.49M. VTGN’s [@Biotechnology] market capitalization is $74.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMEA’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • BMEA’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than BMEA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMEA’s TA Score shows that 5 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • BMEA’s TA Score: 5 bullish, 4 bearish.
  • VTGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than BMEA.

Price Growth

BMEA (@Biotechnology) experienced а -7.50% price change this week, while VTGN (@Biotechnology) price change was +7.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

BMEA is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMEA($105M) has a higher market cap than VTGN($74.4M). VTGN YTD gains are higher at: -13.559 vs. BMEA (-52.320). VTGN has higher annual earnings (EBITDA): -52.22M vs. BMEA (-130.93M). VTGN has more cash in the bank: 88.6M vs. BMEA (35.9M). VTGN has less debt than BMEA: VTGN (1.71M) vs BMEA (7.93M). VTGN has higher revenues than BMEA: VTGN (698K) vs BMEA (0).
BMEAVTGNBMEA / VTGN
Capitalization105M74.4M141%
EBITDA-130.93M-52.22M251%
Gain YTD-52.320-13.559386%
P/E RatioN/AN/A-
Revenue0698K-
Total Cash35.9M88.6M41%
Total Debt7.93M1.71M463%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMEAVTGN
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BMEA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRGC0.120.02
+24.32%
BrightRock Gold Corp.
SPXSF83.12N/A
N/A
SPIRAX GROUP PLC
ECRTF1.52N/A
N/A
Atex Resources Inc.
SSBP9.10N/A
N/A
SSB Bancorp Inc.
ZEOOF9.35N/A
N/A
Zeon Corp.

BMEA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMEA has been closely correlated with CSCI. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BMEA jumps, then CSCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMEA
1D Price
Change %
BMEA100%
-3.14%
CSCI - BMEA
66%
Closely correlated
+5.61%
CCCC - BMEA
46%
Loosely correlated
+6.42%
VTGN - BMEA
39%
Loosely correlated
+0.39%
CAI - BMEA
37%
Loosely correlated
-3.50%
ZLDAF - BMEA
37%
Loosely correlated
+0.05%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+0.39%
ABOS - VTGN
44%
Loosely correlated
+1.35%
COGT - VTGN
42%
Loosely correlated
+2.38%
IMNM - VTGN
42%
Loosely correlated
+1.24%
IPSC - VTGN
41%
Loosely correlated
+0.10%
ALEC - VTGN
40%
Loosely correlated
-4.79%
More